Image
HealthCheck360 Partners With Fern Health to Provide Digital Solutions for Chronic Musculoskeletal Pain
07 févr. 2022 08h00 HE | HealthCheck360
DUBUQUE, Iowa, Feb. 07, 2022 (GLOBE NEWSWIRE) -- HealthCheck360, a leader in population health management and well-being programs for employers, is expanding its program to address the underlying...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
24 janv. 2022 07h00 HE | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
SPR Therapeutics LOGO 361 TM.jpg
The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain Medicine Meeting Receive President’s Choice Award
18 nov. 2021 12h32 HE | SPR Therapeutics, Inc.
CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics has been honored with three President’s Choice Abstract Awards at the 20th Annual ASRA Pain Medicine Meeting taking place November 18-20...
Inagene Logo.jpg
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
16 nov. 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Logo.jpg
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
09 nov. 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Focused on The Future of Innovation, Personalized Medicine and Genomics, the 21st Annual Healthcare Summit brought together global healthcare experts,...
TIP_link_300x300.jpg
Intrathecal Pumps Market Size ($513.24Mn by 2028) Growth Forecast at 5.3% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
07 oct. 2021 07h08 HE | The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Intrathecal Pumps Market: Key InsightsAccording to our new research study on “Intrathecal Pumps Market to 2028 – Global Analysis and Forecast – by Type,...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Next Wave of Psychedelic Drug Development
30 sept. 2021 08h30 HE | Tryp Therapeutics Inc.
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Investors Turning to Psychedelic...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Redefining Standards, Refining Psychiatry
28 sept. 2021 08h30 HE | Tryp Therapeutics Inc.
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
TIP_link_300x300.jpg
Medical Photobiostimulation System Market to Outstrip $314.88 Million by 2028 Growing Sturdy at 6.3% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
12 août 2021 09h39 HE | The Insight Partners
Pune, INDIA., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Medical Photobiostimulation System Market: Key InsightsAccording to our new research study on “Medical Photobiostimulation System Market to 2028 –...
CCM Logo.jpg
Leaf411: Increase in Opioid-related Overdoses Creates Urgency to Educate on Cannabis Treatments for Chronic Pain
10 août 2021 11h00 HE | The 9th Block
DENVER, Aug. 10, 2021 (GLOBE NEWSWIRE) -- According to the U.S. Department of Health and Human Services, two-thirds of all drug overdoses in the country involve an opioid, and overdose deaths...